Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.
Also called NCT07795593
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT07795593
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07795593. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2031-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
- Acronym
- MCPAIN
- Condition
- Painful Diabetic Neuropathy (PDN)
- Condition
- Diabetic Nephropathies
- Intervention (Device)
- Cognitive Behavioral Therapy (CBT)
- Intervention (Drug)
- Oral Medication
- Intervention (Drug)
- Topical Medication
- Lead sponsor
- University of Michigan
- Collaborator
- Patient-Centered Outcomes Research Institute
Record details
- Record id
cardio:ct-nct07795593- Content hash
c5816f7298f099d65f81b0178a0dc25a06a0f962196c06470a195c1c3208bf65